BofA Merrill Lynch, UBS Finance $5.5B Lonza Acquisition of Capsugel

Swiss biotechnology company Lonza will acquire Capsugel for $5.5 billion, including refinancing of existing Capsugel debt of $2 billion. Bank of America Merrill Lynch and UBS have committed financing to support the transaction.